JPMorgan Chase & Co. Trims Stock Holdings in Option Care Health, Inc. $OPCH

JPMorgan Chase & Co. decreased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 36.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 754,845 shares of the company’s stock after selling 439,421 shares during the quarter. JPMorgan Chase & Co.’s holdings in Option Care Health were worth $20,954,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the stock. Mirabella Financial Services LLP purchased a new position in shares of Option Care Health in the third quarter valued at $365,000. Allworth Financial LP lifted its holdings in Option Care Health by 31.3% during the 3rd quarter. Allworth Financial LP now owns 2,938 shares of the company’s stock worth $82,000 after purchasing an additional 701 shares in the last quarter. Swiss Life Asset Management Ltd bought a new position in Option Care Health in the 3rd quarter worth about $217,000. CIBC Bancorp USA Inc. purchased a new position in Option Care Health during the 3rd quarter valued at about $488,000. Finally, Danske Bank A S purchased a new position in Option Care Health during the 3rd quarter valued at about $909,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on OPCH. Bank of America increased their price target on shares of Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a report on Tuesday, December 9th. Citizens Jmp reaffirmed a “market outperform” rating and set a $38.00 price objective (up from $36.00) on shares of Option Care Health in a research note on Tuesday, January 13th. National Bank Financial set a $37.00 target price on shares of Option Care Health in a report on Tuesday, January 27th. Barrington Research raised their price target on shares of Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a report on Friday, January 16th. Finally, Stephens upgraded shares of Option Care Health to a “strong-buy” rating in a research report on Thursday, December 11th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $37.27.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $28.41 on Wednesday. The business’s 50-day moving average price is $33.08 and its two-hundred day moving average price is $30.75. Option Care Health, Inc. has a twelve month low of $24.24 and a twelve month high of $36.80. The stock has a market cap of $4.44 billion, a P/E ratio of 22.20, a PEG ratio of 1.59 and a beta of 0.85. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 0.87.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Tuesday, February 24th. The company reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Option Care Health had a return on equity of 18.57% and a net margin of 3.67%.The company had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion. During the same quarter in the previous year, the firm earned $0.44 earnings per share. Option Care Health’s revenue was up 8.8% on a year-over-year basis. As a group, equities analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.